ODEM  Vol.3 No.3 , August 2015
Nanotoxicology and Exposure in the Occupational Setting
Abstract: Nanotechnology refers to the ability to control the composition of molecules and atoms within the range of 1.00 - 100 nm. At this scale, many materials exhibit novel properties when compared with their micro or macro-sized equivalents, including, for example, chemical reactivity, strength, mobility and solubility. Nanoparticles are prime candidates for toxicity because they possess a much greater surface to volume ratio (i.e. the surface area compared to the volume) than larger particles of that same material; they can have biopersistance and higher oxidant capacity, penetrate epithelium and reach interstitial pulmonary region. In an industrial setting, workers may present the main exposure risk potential among humans, and they may be involved in the entire product life cycle. There are needs to protect public and environmental health and safety. Currently, no standards or regulations exist that apply or refer specifically to nanomaterials impacts.
Cite this paper: Peixe, T. , Souza Nascimento, E. , Schofield, K. , Arcuri, A. and Bulcão, R. (2015) Nanotoxicology and Exposure in the Occupational Setting. Occupational Diseases and Environmental Medicine, 3, 35-48. doi: 10.4236/odem.2015.33005.

[1]   NANO—National Nanotechnology Initiative So What Is Nanotechnology?

[2]   Schulte, P.A. and Buentello, F.S. (2007) Ethical and Scientific Issues of Nanotechnology in the Workplace. Environmental Health Perspectives, 115, 5-12.

[3]   SCENIHR—The Scientific Committee on Emerging and Newly Identified Health Risks, European Commission (2006) What Is Nanotechnology?

[4]   RSC—Royal Society of Chemistry (2009) The Future for Nanoscience and Nanotechnology.

[5]   Seong, S.O.O., et al. (2014) Organization of Research Team for Nano-Associated Safety Assessment in Effort to Study Nanotoxicology of Zinc Oxide and Silica Nanoparticles. International Journal Nanomedicine, 9, 3-10.

[6]   Lux Research (2008) The Nanotech Report. 4th Edition, Lux, New York, 246 p.

[7]   Royal Society and Royal Academy of Engineering (2014) Nanoscience and Nanotechnologies: Opportunities and Uncertainties. RS-RAE, London.

[8]   KAS (2009) Are Nano EHS Budgets Too Small? Environmental Health, Occupational Health & Safety, the Pump Handle.

[9]   Balbus, J.M., Castranova, V., Colvin, V.L., Daston, G.P., Denison, R.A. and Maynard, A.D. (2007) Meeting Report: Hazard Assessment for Nanoparticles—Report from an Interdisciplinary Workshop. Environmental Health Perspectives, 115, 1654-1660.

[10]   Cohen, B.S., Li, W., Xiong, J.Q. and Lippmann, M. (2000) Detecting H+ in Ultrafine Ambient Aerosol Using Iron Nano-Film Detectors and Scanning Probe Microscopy. Applied Occupational and Environmental Hygiene, 15, 80-89.

[11]   Frampton, M.W. (2000) Systemic and Cardiovascular Effects of Airway Injury and Inflammation: Ultrafine Particle Exposure in Humans. Presented at the Workshop in Inhaled Environmental/Occupational Irritants and Allergens: Mechanisms of Cardiovascular and Systemic Responses, Scottsdale, 31 March-2 April, 529-532.

[12]   Hamoir, J., Gustin, P., Halloy, D., Nemmar, A., Nemery, B., Vanderplasschen, A., Vincke, G. and Wirth, D. (2003) Effect of Polystyrene Particles on Lung Microvascular Permeability in Isolated Perfused Rabbit Lungs: Role of Size and Surface Properties. Toxicology and Applied Pharmacology, 190, 278-285.

[13]   Kreyling, W.G., Erbe, F., Mayer, P., OberdÖrster, G., Semmler, M., Schultz, H. and Takenaka, S. (2002) Translocation of Ultrafine Insoluble Iridium Particles from Lung Epithelium to Extrapulmonary Organs Is Size Dependant but Very Low. Journal of Toxicology and Environmental Health, 65, 1513-1530.

[14]   Labhasetwar, V., Sog, C., Humphrey, W., Shebuski, R. and Levy, R.J. (1998) Arterial Uptake of Biodegradable Nanoparticles: Effect of Surface Modifications. Journal of Pharmaceutical Sciences, 87, 1229-1234.

[15]   OberdÖrster, G., Sharp, Z., Atudorei, V., Elder, A., Gelein, R., Kreyling, W. and Cox, C. (2004) Translocation of Inhaled Ultrafine Particles to the Brain. Inhalation Toxicology, 16, 437-445.

[16]   Nel, A. (2005) Air Pollution-Related Illnesses: Effects of Particles. Science, 308, 804-806.

[17]   Nel, A. (2006) Toxic Potential of Materials at the Nanolevel. Science, 311, 622-627.

[18]   Hussain, S.M., Braydich-Stolle, L.K., Schrand, A.M., Murdock, R.C., Yu, K.O., Mattie, D.M., Schlager, J.J. and Terrones, M. (2009) Toxicity Evaluation for Safe Use of Nanomaterials: Recent Achievements and Technical Challenges. Advanced Materials, 21, 1549-1559.

[19]   Borm, P.J.A. (2002) Particle Toxicology: From Coal Mining to Nanotechnology. Inhalation Toxicology, 14, 311-324.

[20]   Henneberger, A., Cyrys, J., Couderc, J.P., Ibald-Mulli, A., Rückerl, R. and Wojciech, Z. (2005) Repolarization Changes Induced by Air Pollution in Ischemic Heart Disease Patients. Environmental Health Perspectives, 113, 440- 446.

[21]   Nemmar, A., Hoylaerts, M.F., Hoet, P.H.M., Dinsdale, D., Smith, T. and Xu, H. (2002) Ultrafine Particles Affect Experimental Thrombosis in an in Vivo Hamster Model. American Journal of Respiratory and Critical Care Medicine, 166, 998-1004.

[22]   OberdÖrster, G., OberdÖrster, E. and OberdÖrster, J. (2005) Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles. Environmental Health Perspectives, 113, 823-839.

[23]   EU-OSHA—European Agency for Safety and Health at Work (2009) European Risk Observatory Report—Literature Review.

[24]   EU-OSHA—European Agency for Safety and Health at Work (2009) European Risk Observatory Report—Expert Forecast on Emerging Chemical Risks Related to Occupation Safety and Health. EN 8.

[25]   Tinkle, S.S., Antonini, J.M., Rich, B.A., Roberts, J.R., Salmen, R. and Depree, K. (2003) Skin as a Route of Exposure and Sensitization in Chronic Beryllium Disease. Environmental Health Perspectives, 111, 1202-1208.

[26]   BSI (2005) British Standards, PAS 71. Publicity Available Specification on Vocabulary—Nanoparticle.

[27]   Oberd?rster, G. (2007) Biokinetics and Effects of Nanoparticles. In: Simeonova, P.P., Opopol, N. and Luster, M.I., Eds., Nanotechnology-Toxicological Issues and Environmental Safety, NATO Science for Peace and Security Series-C, Environmental Security, Springer, Dordrecht, 15-51.

[28]   Chan-Remillard, S., Kapustka, L. and Goudey, S. (2009) Nanotechnology. In: Linkov, I. and Steevens, J., Eds., Nanomaterials: Risks and Benefits, NATO Science for Peace and Security Series-C, Environmental Security, Springer, Dordrecht, 53-66.

[29]   Englert, N. (2004) Fine Particles and Human Health—A Review of Epidemiological Studies. Toxicology Letters, 149, 235-242.

[30]   Kim, C. and Jaques, P.A. (2004) Analysis of Total Respiratory Deposition of Inhaled Ultrafine Particles in Adult Subjects at Various Breathing Patterns. Aerosol Science and Technology, 38, 525-540.

[31]   Shin, J.H., Han, S.G., Kim, J.K., Kim, B.W., Hwang, J.H., Lee, J.S., et al. (2015) 5-Day Repeated Inhalation and 28-Day Post-Exposure Study of Graphene. Nanotoxicology, 20, 1-9.

[32]   Chakrabarti, B., Singh, M. and Sioutas, C. (2004) Development of a Near-Continuous Monitor for Measurement of the Sub-150 nm PM Mass Concentration. Aerosol Science and Technology, 38, 239-252.

[33]   Warheif, D.B., Laurence, B.R., Reed, K.L., Roach, D.H., Reynolds, G.A.M. and Webb, T.R. (2004) Comparative Pulmonary Toxicity Assessment of Single-Wall Carbon Nanotubes in Rats. Toxicological Sciences, 77, 117-125.

[34]   Bowman, D.M. and Calster, V.G. (2008) Reelecting on REACH: Global Implications of the European Union’s Chemicals Legislation. Nanotechnology Law and Business. E.C., Brussels.

[35]   Oberd?rster, G., Morrow, P.E. and Spurny, K. (1988) Size Dependent Lymphatic Short Term Clearance of Amosite Fibers in the Lung. The Annals of Occupational Hygiene, 32, 149-156.

[36]   Oberd?rster, G., Ferin, J. and Lehnert, B.E. (1992) Correlation between Particle Size, in Vivo Particle Persistence, and Lung Injury. Presented at the Workshop on Biopersistance of Respirable Synthetic Fibers and Minerals, Lyon, 7-9 September 1992, 173-179.

[37]   Alyaudtin, R.N., Begley, D.J., Kreuter, J., LÖbenberg, R., Ramge, P. and Reichel, A. (2001) Interaction of Poly (butylcyanoacrylate) Nanoparticles with the Blood-Brain Barrier in Vivo and in Vitro. Journal of Drug Targeting, 9, 209-221.

[38]   Harder, V., Gilmour, P.S., Lentner, B., Karg, E., Takenaka, S. and Ziesenis, A. (2005) Cardiovascular Responses in Unrestrained WKY Rats to Inhaled Ultrafine Carbon Particles. Inhalation Toxicology, 17, 29-42.

[39]   Greenemeier, L. (2008) Study Says Carbon Nanotubes as Dangerous as Asbestos. Scientific American.

[40]   ASCC—Australian Safety and Compensation Council (2006) A Review of the Potential Occupational Health & Safety Implications of Nanotechnology. Flinders Consulting Pty Ltd, 77 p.

[41]   Lam, C.W., James, J.T., Mccluskey, R. and Hunter, R.L. (2004) Pulmonary Toxicity of Single-Walled Carbon Nanotubes in Mice 7 and 90 Days after Intratracheal Instillation. Toxicological Sciences, 77, 126-134.

[42]   Raloff, J. (2005) Nano Hazards: Exposure to Minute Particles Harms Lungs, Circulatory System. Science News, 167, 179.

[43]   Takenaka, S, Karg, E., Kreyling, W.G., Lentner, B., Schultz, H. and Ziesenis, A. (2004) Fate and Toxic Effects of Inhaled Ultrafine Cadmium Oxide Particles in the Rat Lung. Inhalation Toxicology, 16, 83-92.

[44]   Maynard, A.D. (2007) Nanotechnology: The Next Big Thing, or Much Ado about Nothing? The Annals of Occupational Hygiene, 51, 1-12.

[45]   Maynard, A.D. Nanotechnology: Assessing the Risk.

[46]   Bulc?o, R.P., Freitas, F.A., Venturini, C.G., Dallegrave, E., Durgante, J., G?ethel, G., Cerski, C.T.S., Zielinsky, P., Pohlmann, A.R., Guterres, S.S. and Garcia, S.C. (2013) Acute and Subchronic Toxicity Evaluation of Poly(e-capro- lactone) Lipid-Core Nanocapsules in Rats. Toxicological Sciences, 132, 162-176.

[47]   Bulc?o, R.P., Freitas, F.A., Dallegrave, E., Venturini, C.G., Baierle, M., Durgante, J., Sauer, E., Cassini, C., Cerski, C.T.S., Zielinsky, P., Salvador, M., Pohlmann, A.R., Guterres, S.S. and Garcia, S.C. (2014) In Vivo Toxicological Eva- luation of Polymeric Nanocapsules after Intradermal Administration. European Journal of Pharmaceutics and Biopharmaceutics, 86, 167-177.

[48]   Bulc?o, R.P., Bubols, G.B., Nascimento, S.S., Gauer, B., Sauer, E., Baierle, M., Char?o, M.F., Moro, A.M., Brucker, N., Bruinsmann, F.A., Schnorr, C., Moreira, J.C.F., Pohlmann, A.R., Guterres, S.S. and Garcia, S.C. (2015) Do Poly- (epsilon-caprolactone) Lipid-Core Nanocapsules Induce Oxidative or Inflammatory Damage after in Vivo Subchronic Treatment? Toxicology Research, No. 4, 994-1005.

[49]   Ema, M., Kobayashi, N., Naya, M., Hanai, S. and Nakanishi, J. (2010) Reproductive and Developmental Toxicity Studies of Manufactured Nanomaterials. Reproductive Toxicology, 30, 343-352.

[50]   Ema, M., Naya, M., Horimoto, M. and Kato, H. (2013) Developmental Toxicity of Diesel Exhaust: A Review of Studies in Experimental Animals. Reproductive Toxicology, 42, 1-17.

[51]   Juch, H., Nikitina, L., Debbage, P., Dohr, G. and Gauster, M. (2013) Nanomaterial Interference with Early Human Placenta: Sophisticated Matter Meets Sophisticated Tissues. Reproductive Toxicology, 41, 73-9.

[52]   Savolainen, K., Pylkkanen, L., Norppa, H., Falck, G., Lindberg, H., Tuomi, T., Vippola, M., Alenius, H., Hameri, K., Koivisto, J., Brouwer, D., Mark, D., Bard, D., Berges, M., Jankowska, E., Posniak, M., Farmer, P., Singh, R., Krombach, F., Bihari, P., Kasper, G. and Seipenbusch, M. (2010) Nanotechnologies, Engineered Nanomaterials and Occupational Health and Safety: A Review. Safety Science, 48, 957-963.

[53]   EPA (U.S. Environmental Protection Agency) (2008) Nanotechnology. Washington DC.

[54]   NIOSH—The National Institute for Occupational Health and Safety (2009) Approaches to Safe Nanotechnology. Managing the Health and Safety Concerns Associated with Engineered Nanomaterials.

[55]   NIOSH—The National Institute for Occupational Health and Safety (2008) Nanotechnology at NIOSH. Washington DC.

[56]   Choi, S.J., Oh, A.J. and Choy, J.H. (2008) Human-Related Application and Nanotoxicology of Inorganic Particles: Complementary Aspects. Journal of Materials Chemistry, 18, 605-712.

[57]   Chen, C., Li, Y.F., Qu, Y., Chai, Z. and Zhao, Y. (2013) Advanced Nuclear Analytical and Related Techniques for the Growing Challenges in Nanotoxicology. Chemical Society Reviews, 42, 8266-8303.

[58]   EU—European Commission. Follow-Up to the 6th Meeting of the REACH Competent Authorities for the Implementation of Regulation (EC) 1907/2006 (REACH) 15-16 December 2008. Doc. CA/59/2008 rev. 1. Accessed: 26 June 2009.

[59]   EURACTIV (2009) “No Data, No Market” for Nanotechnologies, MEPs Say.

[60]   EU—European Commission (2008) REACH in Brief. E.C., Brussels.

[61]   Stern, S.T. and Mcneil, S.E. (2008) Nanotechnology Safety Concerns Revisited. Toxicological Sciences, 101, 4-21.

[62]   Sequeira, R. (2006) The Nano Enterprise: A Survey of Health and Safety Concerns, Considerations, and Proposed Improvement Strategies to Reduce Potential Adverse Effects. Human Factors and Ergonomics in Manufacturing, 16, 343-368.

[63]   Friedrichs, S. and Schulte, J. (2007) Environmental, Health and Safety Aspects of Nanotechnology—Implications for the R&D in (Small) Companies. Science and Technology of Advanced Materials, 8, 12-18.

[64]   The Foresight Institute (2005) Preparing for Nanotechnology. Menlo Park.